… an array of extra-neutralizing antibody effector functions across HIV-infected populations with
… the high potential relevance of maximizing antibody effector function breadth and potency. …

… antibody effector functions relevant to these parasites. Studies that use malaria protein
arrays to profile antibody … are unclear as potent human monoclonal antibodies against the N …

… antibody therapy. Since human IgG1 is the most commonly used antibody isotype in cancer
therapy, antibody … the importance of Fc glycosylation on IgG1 antibody effector function (7–9). …

… of the antibody correlate of HIV-1 risk, we examined antigen-specific antibody recruitment of
Fcγ receptors (FcγRs), antibody-… , antibody-dependent monocyte phagocytosis and antibody …

… binding domain and spike antibodies with Fc-mediated effector functions and cellular CD4 +
… antibody immunity. Our results highlight the potential role of Fc-mediated effector functions …

… Significantly, Fc-mediated antibody effector functions have likewise been associated with …
, we compared the effector function and biophysical features of HIV-specific antibodies in a …

… effector functions to antibody protection against SARS-CoV-2 infection, we profiled
vaccine-induced antibodies … We measured the binding of antibodies to several spike proteins …

… The enhanced CDC killing potency of ofatumumab is due to its binding to a membrane-…
Overwhelmingly, the effector function of therapeutic antibodies is thought to be dominated by …

… potency compared to the J3-bihead and restored Fc-mediated effector functions such as
antibody-… breadth and potency and their ability to induce effector functions these nanobody-IgG1 …

… effector functions. In order to further increase their binding affinities and to restore
antibody-mediated effector functions, … potencies of nanobodies and to re-introduce …